Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03924245
Title	Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers
Recruitment	Terminated
Gender	female
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Vanderbilt-Ingram Cancer Center
Indications	peritoneal carcinoma ovarian carcinoma fallopian tube carcinosarcoma ovarian carcinosarcoma fallopian tube carcinoma
Therapies	Entinostat Entinostat + Olaparib
Age Groups:	senior \| adult
Covered Countries	USA